MA-PRESS-GANEY
Press Ganey , a renowned leader in patient, member, employee and consumer experience across the healthcare ecosystem, today announced its plans to acquire Forsta , an industry-leading global provider of customer experience and market research technology. Forsta is named a Leader in the 2021 Gartner® Magic Quadrant™ for Voice of the Customer. The transaction is expected to close in the first or second calendar quarter of 2022, and is subject to regulatory approvals and other customary closing conditions.
“This alliance propels Press Ganey into a new future. Our unparalleled excellence in healthcare consulting, and proprietary data and analytics, will soon be infused with even more innovation and speed by Forsta’s world-class experience and research technology platform,” said Patrick T. Ryan, Chairman and CEO, Press Ganey. “I’m beyond thrilled to welcome Forsta to the Press Ganey family. This is a huge leap forward in helping our customers to do their jobs better every day.”
This pairing drives Press Ganey forward on its path to integrating human-centric, cutting-edge technology into its renowned thought leadership and management expertise in healthcare. Press Ganey’s clients will have access to an even more powerful suite of customer experience (CX), employee experience (EX), and Market Research (MR) technology options on Forsta’s comprehensive platform. Forsta also brings extensive knowledge across a number of industry verticals, such as retail, financial services, travel and hospitality, technology, entertainment and consumer goods. The company works with world-leading brands, including Avon, Best Buy, Canon, eBay, Heathrow Airport and Mars, Inc.
For Forsta, teaming up with healthcare performance advancement pioneer Press Ganey brings new access to investment, growth opportunities and deep consulting and change management experience across the complex healthcare ecosystem. Press Ganey gives Forsta the resources to continue to innovate, at an accelerated pace. And Press Ganey’s gold standard CX and EX capabilities in healthcare will equip Forsta with decades of expertise in this vertical.
“Press Ganey was the first company to truly recognize and respond to the importance of Patient Experience, and the company continues to lead innovation in the field. I’m excited to join forces with such a forward-thinking, highly respected company, and eager for the benefits this investment will bring to our customers,” said Kyle Ferguson, CEO, Forsta.
Combined, Press Ganey and Forsta serve the experience and insights needs of millions of organizations:
- 100% of U.S. News & World Report Best Hospital and Best Children’s Hospital Honor Roll recipients use Press Ganey.
- Press Ganey manages approximately 476 million patient engagements every year.
- Forsta’s HX (Human Experience) platform serves over 5,000 customers in more than 100 countries around the world.
- Forsta supports 9 of the top 10 Market Research Agencies globally.
“This move is the culmination of Press Ganey’s investments to not just be leaders in the healthcare industry, but to lead in experience technology, too. Forsta’s HX platform will allow Press Ganey to make a quantum leap in our technology solutions for our clients,” said Darren Dworkin, Chief Strategy Officer, Press Ganey. “Together, the next generation of patient and customer experience will be better, deeper and truly human-centric.”
About Press Ganey
Press Ganey invented the healthcare performance improvement movement over 35 years ago. Today it offers an integrated suite of solutions that address safety, clinical excellence, patient experience and workforce engagement. The company works with more than 41,000 healthcare facilities in its mission to reduce patient suffering and enhance caregiver resilience to improve the overall safety, quality and experience of care.
About Forsta
Forsta is an Experience and Research Technology Platform that gathers and analyzes data, and translates the findings into shareable actions to inform decision-making and drive growth. Forsta’s technology is designed to discover, analyze and share smart insights packed with real action potential, and help organizations better understand the full Human Experiences of their audiences.
View source version on businesswire.com: https://www.businesswire.com/news/home/20220207005510/en/
Link:
Social Media:
About Business Wire
Subscribe to releases from Business Wire
Subscribe to all the latest releases from Business Wire by registering your e-mail address below. You can unsubscribe at any time.
Latest releases from Business Wire
Thales Reinforces its Leadership in eSIM and IoT Connectivity with a ‘Ready to Use’ Certified Solution8.7.2025 08:00:00 CEST | Press release
At a time when billions of connected objects are reshaping industries, Thales has achieved an essential security certification for its eSIM solution, reinforcing its leadership in trusted connectivity management for the Internet of Things (IoT). The certification, granted by the GSMA under the eSIM Security Assurance (eSA) scheme, marks a significant milestone in enabling large-scale, secure, and efficient IoT deployments across industries including smart metering, healthcare, and automotive. This positions Thales as a trusted partner capable of providing full protection against advanced cyber threats — delivering end-to-end security solutions, from chip to cloud, and ensuring compliance with emerging security standards (e.g., the EU Cyber Resilience Act). With over 5.8 billion IoT cellular connections expected globally by 2030 (GSMA Intelligence), businesses and industries face growing pressure to deploy connected devices at scale — securely and efficiently. The SGP.32 IoT specificati
Invivoscribe Expands Flow Cytometry Services to Accelerate CAR-T Immunotherapy Development and Regulatory Readiness with the Initiation of CERo Therapeutics Phase 1 Clinical Trial8.7.2025 06:00:00 CEST | Press release
Invivoscribe Inc., a global leader in precision diagnostics and measurable residual disease (MRD) testing, is proud to support CERo Therapeutics Holdings, Inc., an innovative immunotherapy company seeking to advance the next generation of engineered T cell therapeutics that employ phagocytic mechanisms. Through this collaboration, LabPMM (Invivoscribe’s global reference laboratories) have customized their multiparametric flow cytometry (MFC) services and implemented their sensitive MFC AML MRD assay to supportCERo’s clinical trial of its lead compound, CER-1236. The trial targets Acute Myeloid Leukemia (AML) in patients who are relapsed/refractory, in remission with MRD, or newly diagnosed with TP53-mutated MDS/AML. AML is an aggressive blood cancer characterized by the rapid accumulation of abnormal myeloid cells in the bone marrow and blood, disrupting normal hematopoiesis.1 Treating AML is especially complex due to its genetic heterogeneity and the high risk of relapse. CAR-T (chime
Tigo Energy Adds Solar-Plus-Storage Portfolio in Czech Republic to Build on MLPE Success8.7.2025 06:00:00 CEST | Press release
Successful PPDS P4 protocol certification opens full range of three-phase Tigo EI Inverters and the EI Residential product suite for grid connection in second-strongest E.U. market for Tigo. Tigo Energy, Inc. (NASDAQ: TYGO) (“Tigo” or “Company”), a leading provider of intelligent solar and energy software solutions, today announced that the Company’s entire portfolio of three-phase Tigo EI Inverters has successfully passed the certification tests for compliance with the PPDS P4 requirements in the Czech Republic. Compliance with PPDS P4, formally known as Distribution System Operation Rules, Annex 4, is a prerequisite for grid connection of solar inverters in the Czech Republic, validating the compatibility with the technical conditions defined by the European Commission and adopted by local utility companies. In the wake of the proliferation of rapid shutdown requirements across Europe, with installers in the Czech Republic deploying nearly 107MW of Tigo MLPE in 2024, Tigo products ha
Murata Launches World’s First High-Frequency Filter Using XBAR Technology for 5G, Wi-Fi 7, and Future 6G Networks8.7.2025 04:00:00 CEST | Press release
Murata Manufacturing Co., Ltd. (TOKYO: 6981) (ISIN: JP3914400001) has announced the mass production and commercial shipment of the world’s first*1 high-frequency filter using XBAR technology*2. Developed by combining Murata’s proprietary Surface Acoustic Wave (SAW) filter expertise with XBAR technology from Murata's subsidiary Resonant Inc., it enables the extraction of desired signals while achieving both low insertion loss and high attenuation. These features are critical for the latest wireless technologies, including 5G, Wi-Fi 6E, Wi-Fi 7, and emerging 6G technologies. This press release features multimedia. View the full release here: https://www.businesswire.com/news/home/20250707682186/en/ [Murata Manufacturing Co., Ltd.] The world’s first high-frequency filter using XBAR technology The demand for reliable high-frequency communications continues to grow in response to the widespread deployment of 5G and the future development of 6G. Simultaneously, wireless local-area network (W
YES Delivers Multiple VertaCure LX Systems7.7.2025 21:34:00 CEST | Press release
Yield Engineering Systems (YES), a leading provider of process equipment for AI and HPC semiconductor applications, today announced the delivery of multiple VertaCure™ LX curing systems to one of Taiwan’s top outsourced semiconductor assembly and test (OSAT) providers. These systems will support advanced packaging processes for Edge Computing and HPC solutions, delivering critical low-temperature curing, annealing, and degassing for WLCSP, Plated Bump, and Cu Pillar applications. This press release features multimedia. View the full release here: https://www.businesswire.com/news/home/20250703001376/en/ VertaCure LX The VertaCure LX is a fully automated vacuum curing and degassing system engineered to ensure uniform temperature distribution and precise control of heating and cooling rates. This results in complete solvent removal, improved film properties, elimination of outgassing after cure, and outstanding particle performance. YES products have consistently demonstrated superior qu
In our pressroom you can read all our latest releases, find our press contacts, images, documents and other relevant information about us.
Visit our pressroom